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The development of a disposable immunosensor based on a
hybrid gold­carbon screen-printed electrode array is described.
The electrodeposition of gold is shown to lead to a ﬁeld
of nanocrystals that facilitates antibody immobilization and
enhances electron transfer. A label-free analysis protocol based
on ferrocyanide has been developed for the detection of Prostate
Speciﬁc Antigen in the fgmL¹1 range.
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Prostate cancer (PCa) is a signiﬁcant cause of morbidity
and mortality and the most common cancer in men in Europe,
North America, and some parts of Africa.1­3 The disease can be
particularly problematic from an observational diagnostic
perspective as symptoms may not become apparent until the
cancer is in its advanced stages. A second issue arises from the
fact that there can be considerable reluctance on the part of the
patient to actively request medical advice.4 Even where help is
sought, clinical assessment can be ambiguous as many of the
complaints are seldom speciﬁc to PCa and can easily be
attributed to a host of other non-cancerous conditions such as
infection or inﬂammation. There are many issues that can
impede early diagnosis and, all too often, the cancer is not
detected until the cancer has spread.4 The need for rapid
screening diagnostics for PCa has long been recognized and
there have been some measures to proactively screen those
sectors of the populace who are deemed to be “at risk”. Prostate
cancer incidence is strongly linked to age and seldom diagnosed
in those younger than 50 years. It has been reported that in the
UK (between 2009 and 2011 some 36% of new cases were
diagnosed in older men (>75 years) with under 50s accounting
for only 1%.5
The concentration of Prostate Speciﬁc Antigen (PSA) in
serum is presently the principal screening biomarker for PCa
and has use in the staging and post therapy monitoring of the
disease.6,7 It has been established that the majority of men
diagnosed with PCa will have clinically impalpable carcinoma
with elevated levels of serum PSA in the range of 2.5­
10.0 ngmL¹1.8 There is however a positive predictive value
(PPV) of elevated serum PSA for the detection of PCa but this
largely depends on the deﬁnition of an optimal upper limit of
“normal” PSA levels.6 The PPV for histological diagnosis of
PCa with serum PSA >4 ngmL¹1 has been reported to lie
between 31­51%.9 At high serum PSA levels (>10 ngmL¹1),
the probability of disease detection is ca. 60%. However, as
most men present with levels lower than 10 ngmL¹1 there is
a continuing challenge to improve the PPV of serum PSA, In
response, various adaptations to the basic PSA assay have been
developed and include: proPSA, PSA doubling time (PSADT),
age-speciﬁc PSA, PSA velocity (PSAV, rate of change of PSA
levels over time), PSA density (PSAD = serum PSA/ultrasound
volume of the prostate gland), free PSA (fPSA), percent free
PSA (%fPSA), complexed PSA, and benign PSA (BPSA).10­12
A detailed description of these assays is provided elsewhere4 but
irrespective of the assay type: the central limitation is that the
analysis is done within a central laboratory. There remains a
pressing need to provide much more routine screening within
the primary care sector and it is little surprise to ﬁnd that the
sensor community continues to explore the development of PSA
technologies.
Some of more recent developments in PSA immunosensing
technologies include ﬁeld eﬀect devices,13,14 microbalances and
nanoresonators15,16 but most activity is directed towards modi-
ﬁed electrode systems: typically employing nanoparticles and
2D materials.17­22 The use of screen-printed electrode (SPE)
systems is arguably the more commercially viable and provides
a disposable format which is particularly suited towards a
clinical environment. The aim of the present communication has
been to explore the development of a modiﬁed SPE capable
of detecting PSA within the desired clinical range and which
could possess suﬃcient versatility to be expanded to the other
PSA assay variations noted earlier. The basic approach to the
fabrication of the sensing strip is highlighted in Figure 1 and
consists of a series of surface modiﬁcations.
The electrodeposition of the gold sublayer is a critical
component as it provides the means through which to anchor the
antibody and, it was envisaged, would enhance the response to
the redox probe. The latter is an important consideration as the
Figure 1. Assembly steps in production of the nanocrystalline
Au­carbon immunosensor. 1) Electrodeposition of Au onto
carbon screen-printed electrode. 2) Functionalization of Au layer
with mercaptopropionic acid (MPA). 3) Activation of carboxy
groups with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
hydrochloride (EDC) and N-hydroxysuccinimide (NHS). 4)
Coupling of PSA antibody to modiﬁed electrode.
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analytical signal is determined through the oxidation of
ferrocyanide at the underlying substrate. Ferrocyanide was
chosen on the basis of its reversible electrode behavior at gold
and low oxidation potential which could aid discrimination from
common electroactive interferences such as urate and ascorbate.
Other mediators with lower oxidation potentials such as
riboﬂavin have been used in immunosensors23 but these can
fall foul of oxygen interference. The general label-free detection
methodology is highlighted in Figure 2. The binding of the
PSA to the immobilized antibody reduces the access of the
ferrocyanide probe to the electrode and consequently there is a
reduction in the current. In the present paper, cyclic voltammetry
is used to probe the antigen­antibody interactions.
All chemicals were obtained from Sigma-Aldrich, were
the highest grade available and were used without further
puriﬁcation. Electrochemical analysis was carried out using a
VSP-300 Multichannel Potentiostat/Galvanostat/EIS (Bio-
Logic Science Instruments, EC-Lab Ltd.) with a standard three-
electrode conﬁguration with a carbon screen-printed working
electrode, a platinum wire counter electrode, and a standard
silver/silver chloride (3M NaCl, BAS Technicol UK) reference
electrode. All measurements were conducted at 22 « 2 °C.
Screen-printed electrodes (SPEs) were fabricated using a
DEK 240 Manual Screen Printing Machine using a stainless-
steel screen mesh and commercial graphite ink (Gwent Elec-
tronic Materials (GEM) Product code: C205010697). Initially,
the base of the SPE was printed onto a Valox substrate which
was cured at 70 °C for 90min. To deﬁne the working area, a
polymeric dielectric material (GEM Product code: D2071120P1)
was then screen-printed onto the cured SPE. A JEOL JSM-6010
Plus scanning electron microscope (SEM) was used to character-
ize the surface morphology of the carbon sensors and a
representative micrograph of the carbon print morphology and
the nanoporous nature of the deposit is highlighted in Figure 3A.
The screen-printed array is detailed in Figure 3B along with
the surface roughness results obtained from the application of a
DEKTAK XT Stylus Proﬁler (Bruker) system. The results from
three electrodes are compared in Figure 3B and it can be seen
that the typical thickness of the print is of the order of 20 micron.
It has become relatively common to electrochemically
anodise carbon composite electrodes in order to elicit improved
electrochemical behavior.24,25 The electro-oxidation (+2V,
0.1M NaOH) typically increases exfoliation of the carbon
particles®generating more edge plane sites and increases the
populations of various oxygen functional groups.24,25 This
process was also instituted here where it has been found that
the unmodiﬁed screen-printed electrodes typically exhibit poor
electrochemical behavior with large overpotentials necessary to
obtain any signiﬁcant analytical responses.24
The electrodes were further modiﬁed through the electro-
deposition of a gold layer. This was achieved through employing
cyclic voltammetry whereby the pre-anodized screen-printed
electrode was immersed in a gold(III) chloride solution (6mM
NaAuCl4, 0.1M HNO3) and scanned between ¹0.2 and 1.6V
for 20 scans at 0.1V s¹1. The electrodes were then removed,
rinsed, and dried. Scanning electron micrographs of the gold
deposit are shown in Figure 4. The initial carbon deposit shown
in Figure 3A details a highly microporous morphology. The
electrodeposition of the gold however appears to decorate the
carbon substructure with a ﬁeld of discrete nanocrystal deposits.
The ﬁnal stage in the sensor assembly involved the
immobilization of the PSA antibodies. The gold­carbon SPE
was ﬁrst immersed into a solution of 3-mercaptopropionic acid
(MPA) (10mM, deionized water) for one hour, rinsed and then
placed in a solution containing equimolar 1-ethyl-3-(3-dimethyl-
aminopropyl)carbodiimide hydrochloride and N-hydroxysucci-
nimide (0.04M) for 30min. The electrodes were removed and
spotted with a 0.2mgmL¹1 solution of the PSA antibody and
left overnight (ca. 18 h). The electrodes were thoroughly rinsed
Figure 2. Schematic highlighting the eﬀect of antigen binding
on the cyclic voltammetric response to a generic mediator (M).
Figure 3. A) Scanning electron micrograph of the carbon
surface on the working electrode disc. Inset: Digital images of the
complete printed array and the working electrodes. B) DEKTAK
surface proﬁle comparison of three working electrodes.
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with phosphate buﬀered saline (PBS) and then left in a solution
of 1% bovine serum albumin for one hour to block any
remaining sites and then rinsed with PBS. This is a critical
component in the overall assembly process as the presence of
unblocked areas on the electrode surface and the easy access of
ferrocyanide could come to dominate the analytical signal and
reduce the sensitivity to antigen binding.26,27
Cyclic voltammograms comparing the response of the
screen-printed sensor to ferrocyanide before and after the
electrodeposition of gold are detailed in Figure 5. The bare,
unmodiﬁed carbon exhibits relatively poor performance in terms
of the oxidation of ferrocyanide (2mM, 0.1M KCl) with the
peak observed at +0.457V. Similarly, the reduction process is
poor with a peak separation of more than 400mV. This is
attributed to the carbon particles within the ink formula
consisting of predominantly basal planes.24,25 The response to
ferrocyanide after the electro-deposition of the gold stands
in marked contrast with superior peak deﬁnition. The peak
magnitude of the gold SPE is more than double that of the bare
carbon with increased reversibility of the redox system where the
peak separation has decreased to 71mV. The acquisition of a
sharp unambiguous peak process at a low operating potential is a
critical factor for the successful deployment of the methodology
advocated in Figure 2. In the case of the unmodiﬁed carbon
electrode, the overpotential required before any appreciable
oxidation current is observed would inevitably induce the
oxidation of other matrix components®lead to signal ampliﬁ-
cation and compromise the interpretation of the response.
The oxidation peak observed with the gold-modiﬁed system
(+0.257V) markedly reduces the likelihood of such interference.
Surface modiﬁcation of the gold with a sequence of protein
coupling agents: MPA/EDC/NHS and the PSA antibody leads
only to minor modiﬁcation of the electrode response as indicated
in Figure 6 where the ferrocyanide oxidation and reduction
peaks are still clearly visible. The addition of aliquots of PSA
(10 fgmL¹1, 0.01M PBS) lead to a successive decrease in the
oxidation peak height consistent with the label-free detection
methodology highlighted in Figure 2.
The electrode response was found to be consistent with the
work of other research groups employing cyclic voltammetry for
the identiﬁcation and quantiﬁcation of antigen binding events.22
The response observed here however is markedly more sensitive
(LOD: 4.7 fgmL¹1 based on 3Sb) than many of the current
approaches to PSA detection and can be attributed to the high
activity of the underpinning gold layer for both the immobiliza-
tion of the antibody and in facilitating the response to the redox
probe. The reproducibility of the system is highlighted in
Figure 7 where the responses to femtogram amounts of the PSA
are detailed for three individual electrode systems within the
printed array shown in Figure 3B.
While the intrabatch reproducibility highlighted here is
clearly promising, the nature of the steps involved in the
manufacture of the strips would require more elaborate
calibration processes before clinical deployment. The label-free
Figure 4. Scanning electron micrograph of the carbon surface
after the electrodeposition of the gold layer.
Figure 5. Cyclic voltammograms detailing the response of a
carbon screen-printed electrode towards ferrocyanide (2mM,
0.1M KCl, 50mV s¹1) before and after the electrodeposition of
Au. Scan rate: 50mV s¹1.
Figure 6. Cyclic voltammograms detailing the response of an
antibody-modiﬁed gold­carbon screen-printed electrode towards
ferrocyanide (2mM) before and after additions of PSA
(10 fgmL¹1). Scan rate: 50mV s¹1.
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approach advocated here does however oﬀer a much simpler
operational protocol which avoids the multiple washing steps
associated with conventional sandwich assay systems.20­22 A
large variety of nanoparticles have been widely used in the
development of electrochemical immunosensors with the more
recent exploiting Au,17­19 Pt-Cu,18 SiO2,20 TiO2,21 and MoS2.22
Such moieties can however create some issues when considering
the development of disposable arrays and attempting to control
their immobilization at small dimension sensors. Electrodepo-
sition can enable spatial control over the deposition process and,
as indicated in this communication, enables the seeding of the
electrode surface with highly active gold nanostructures. It could
be envisaged that the adoption of square wave voltammetric
detection and the translation of the system to smaller geometries
where reductions in signal background could herald further
gains in sensitivity but these systems invariably come at the
expense of greater instrumentation requirements in terms of
manufacture and clinical operation. The system adopted here
enables rapid manufacture using conventional and accessible
technologies. Moreover, the immobilization process is generic
and, it could be envisaged, the printed array could ultimately
be used to screen for a range of biomarkers and facilitate
multiparametric analysis.
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